: The Rs 250-crore expansion plan of Aurobindo Pharmas manufacturing facility in Srikakulam district of Andhra Pradesh has been accorded environmental clearance by the the Ministry of Environment, Forests and Climate Change.
The plan was for increasing the production capacity of for bulk drugs and intermediates manufacturing unit from 583.31 TPM (tonnes per month) to 1518.3 TPM, a press release said here Monday.
The project involves also installation of a captive power plant of 8.85 MW, the release said.
The project is expected to create jobs for 600 people directly and 120 indirectly, it said.
The estimated cost for expansion is Rs 250 crore. The total capital cost earmarked for environmental pollution control measures is Rs 32.77 crore and the recurring cost (operations and maintenance) would be about Rs 8.84 crore per annum, it said.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
